Bioavailability and Food Effect Study of 3 Types of Carisbamate
Status:
Completed
Trial end date:
2021-10-06
Target enrollment:
Participant gender:
Summary
This study is designed to examine the relative bioavailability of three carisbamate
formulations (Oral Suspension Type 1, Oral Suspension Type 2, and a 300 mg Oral Tablet) and
to assess the effect of food on the oral bioavailability of the Oral Suspension Type 2 and
the 300 mg Oral Tablet.